ArticleJournal of food science2026
Biogenic Amines Control in Bacterial-Type Douchi Using Bacillus velezensis A1: Strain Screening, Process Optimization, and Industrial Validation.
Article in Journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The study focused on biogenic amines (BAs) in fermented products, particularly douchi. Three strains showing high protease activity (> 90.00 U/mL) and low BA levels (< 40 mg/kg) were isolated from naturally fermented douchi: A1 Bacillus velezensis, A2 B. glycinifermentans, and A3 B. subtilis. A1, with the lowest total biogenic amine (TBA) levels, was selected as the representative strain. The optimal fermentation conditions (8% inoculum, 37°C temperature, 3 days duration) reduced TBA to levels well below the FDA standard (< 1000 mg/kg). Compared to the natural fermentation (NF), it was verified that the TBA of douchi was lowered to 10.51 ± 0.21 mg/kg after optimized fermentation, approximately reduced 10.80-fold. Spermine levels decreased by 43.17-fold, followed by tyramine and phenethylamine. Further, apply them to large-scale cultivation (scaled up by 100-fold) in actual production during colony-enhanced fermentation (CEF). The physicochemical properties and BA levels were monitored to assess the correlation. The findings showed that the douchi of CEF had up to 0.94% amino acid nitrogen (≥ 0.25% EN) and 0.72% total acid (≤ 2.5% EN). The TBA level was only 38.27 ± 0.13 mg/kg, significantly lower than NF (94.94 ± 2.59 mg/kg). This study proposed BA-reducing methods through strain screening and process optimization, particularly achieving large-scale verification from the laboratory to the factory. This approach significantly reduced the TBA levels in bacteria-type douchi, offering a crucial reference for the industrial-scale safe production of fermented soybean products. PRACTICAL APPLICATIONS: This research offers industrial-level guidance for douchi production. By utilizing Bacillus velezensis A1 and optimizing the process, the TBA can be reduced by a factor of 2.5 while maintaining product quality (T/GZSX 014-2018). This approach provides a collection of directly applicable safety production technology models for fermented soybean product enterprises, thereby assisting the industry in improving product safety and addressing health consumption demands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.